Table 2. Clinical details, CTC counts and culture observations of short-term culture positive samples.
| Patient # | Subtype | Stage | CTC count/ 7 mL blood |
CTC cluster count/7 mL blood | Culturability |
|---|---|---|---|---|---|
| 7 | Squamous cell carcinoma | IV | 20 | 0 | 30% confluent on day 7, proliferative up to day 20 |
| 17 | Adenocarcinoma | II | 25 | 1 | 10% confluent on day 14, proliferative up to day 40 |
| 25 | Adenosquamous cell carcinoma | IV | 15 | 0 | 50% confluent on day 14, proliferative up to day 20 |
| 34 | Adenocarcinoma | IV | 20 | 0 | 10% confluent on day 14, proliferative up to day 40 |
| 41 | Adenocarcinoma | III | 55 | 5 | 10% confluent on day 14, proliferative up to day 50 |
| 46 | Adenocarcinoma | IV | 5 | 0 | 50% confluent on day 14, proliferative up to day 30 |
| 51 | Adenocarcinoma | IV | 35 | 0 | 30% confluent on day 7, proliferative up to day 20 |
| 58 | Adenocarcinoma | IV | 5 | 0 | 50% confluent on day 14, proliferative up to day 40 |
| 70 | Adenocarcinoma | IV | 5 | 2 | 30% confluent on day 20, proliferative up to day 40 |
CTC, circulating tumour cell.